SCHEMBL8811063

SCHEMBL8811063

CCOC(=O)c1cc2ccc3c(c2cc1O)OC(n1cccc1)=C(C#N)C3c1ccc(Cl)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MYB P10242 6/20 0.38
▸ MAPT P10636 4/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ ALOX5 P09917 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ GAA P10253 2/20 0.34
▸ USP2 O75604 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ALOX12 P18054 1/20 0.34
▸ MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8810581 0.89 MYB (0.48) MYBMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL8809115 0.87 ALDH1A1 (0.42) MYBMAPTALDH1A1MEN1KMT2A
SCHEMBL8808745 0.87 MYB (0.49) MYBMAPTALDH1A1MEN1KMT2A
SCHEMBL8811837 0.86 MYB (0.48) MYBMAPTALDH1A1MEN1KMT2A
SCHEMBL8807532 0.86 MEN1 (0.46) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL8809139 0.77 MYB (0.47) MYBMAPTALDH1A1MEN1KMT2A
SCHEMBL8808823 0.76 MYB (0.50) MYBMAPTALDH1A1MEN1KMT2A
SCHEMBL8810573 0.76 MYB (0.61) MYBMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL8810798 0.74 MPO (0.51) MYBMAPTALDH1A1MEN1KMT2A
SCHEMBL8808977 0.74 MAPT (0.53) MYBMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0618206-B1 Pharmaceutical compounds LILLY INDUSTRIES LTD (GB) 1997-09-17 — — EP disclosed
US-5576325-A TREATMENT OF IMMUNE DISEASES, RESTENOSIS, ENZYME INHIBITORS AND ANTISPASMODIC AGENTS LILLY INDUSTRIES LIMITED (GB) 1996-11-19 — — US disclosed
US-5574034-A TREATMENT OF IMMUNE DISEASES AND EXCESS CELL PROLIFERATION, ENZYME INHIBITORS ELI LILLY AND COMPANY (US) 1996-11-12 — — US disclosed
US-5571818-A FOR TREATING IMMUNE DISEASES OR A DISEASE IN WHICH EXCESS CELL PROLIFERATION OR ENZYME RELEASE OCCUR ELI LILLY AND COMPANY (US) 1996-11-05 — — US disclosed
US-5514699-A Pharmaceutical compounds LILLY INDUSTRIES LIMITED (GB) 1996-05-07 — — US disclosed
EP-0618206-A1 Pharmaceutical compounds LILLY INDUSTRIES LIMITED (GB) 1994-10-05 — — EP disclosed
Send feedback